Is stem cell therapy for Primary Immunodeficiency FDA-approved?
HSCT is an established clinical pathway for selected diagnoses and specific cellular products may have authorised uses; that is not approval of generic stem-cell therapy for immune enhancement. Verify diagnosis, product, donor source and legal indication.
How stem cells are studied for Primary Immunodeficiency
Primary immunodeficiencies, also called inborn errors of immunity, comprise many genetic disorders with different infection, inflammatory, autoimmune and malignancy risks. Haematopoietic stem-cell transplantation (HSCT) can be established or potentially curative for selected severe diagnoses because it replaces the blood-forming immune system. This is not equivalent to an MSC infusion marketed for general immune support.
Am I a candidate? → · Primary Immunodeficiency: full overview → · Primary Immunodeficiency cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.